My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
September 2016
Advocacy for New Antibiotics and Policies to Combat AMR Continues
In addition to the historic United Nations meeting this month, IDSA participated in numerous other meetings and events to advocate for sound public policy on antimicrobial resistance. 
Improving Regulatory Climate for Antibiotic R&D 

IDSA held a meeting with Janet Woodcock, Director of the Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER), to discuss next steps for advancing policies to make it more feasible to conduct clinical trials for new antibiotics that address unmet medical needs. The meeting was a follow-up to an FDA workshop in July entitled: “Facilitating Antibacterial Drug Development for Patients with Unmet Need and Developing Antibacterial Drugs that Target a Single Species.” Discussion covered the scientific challenges pertaining to such development programs, including enrollment challenges, clinical trial designs and trial population. Also in September, the FDA, European Medicines Agency (EMA) and Pharmaceuticals and Medical Devices Agency-Japan (PMDA) issued a promising tripartite agreement regarding regulatory approaches for the evaluation of new antibiotics, which stressed the appropriateness of accepting greater degrees of uncertainty (i.e., smaller clinical trials) for new antibiotics that address an unmet need, the usefulness of other types of supplemental data in addition to clinical trials, and the importance of establishing clinical trials networks. 
IDSA Congressional Briefing 
IDSA co-hosted a congressional briefing in September with the Antimicrobials Working Group (AWG), a coalition of small pharmaceutical companies, to educate congressional staff about the need for new antibiotics, economic incentives, and feasible regulatory policies. IDSA board member Chip Chambers, MD, FIDSA, gave the clinician’s perspective on these issues, joining a panel featuring a sepsis patient, the CEO of Melinta Therapeutics, and an economist from the Duke-Margolis Center for Health Policy. 

Presidential Advisory Council Meeting 
The Presidential Advisory Council on Combating Antibiotic Resistant Bacteria (PACCARB) held a public meeting (PDF) also in September focused on antibiotic stewardship and infection prevention. IDSA Treasurer Helen Boucher, MD, FIDSA, and IDSA Diagnostics Task Force Chair Angela Caliendo, MD, FIDSA, serve on the PACCARB. The PACCARB, at the request of Health and Human Services Secretary Sylvia Burwell, will consider recommendations regarding prioritizing resources to combat antibiotic resistance. IDSA staff provided public comments at the meeting about the importance of a One Health multi-pronged approach to resistance that includes stewardship, infection control and prevention, surveillance and data collection, research, and innovation.

< Previous Article | Next Article >

Post a comment

Your name:

Your comment:

HCV Guidance Panel Recommends Assessment for HBV Prior to Treatment
FDA Issues Ban on Triclosan, CDC Continues to Provide Guidance Throughout Zika Outbreak
Medicare Will Soon Require More Coding Specificity on Claims
Advocacy for New Antibiotics and Policies to Combat AMR Continues
Helping Lawmakers Understand the Importance of LDTs and Risks of Proposed Regs
Join HIVMA for Updates on the Ryan White Program at IDWeek 2016
AIDS, Global Antimicrobial Resistance, Zika: IDSA Global Health Covers the Latest
OFID Podcast Explores Root Causes of Decline in ID Fellowship Applicants
IDSA Education and Research Foundation: Steering Medical Students Toward ID
Consumer Reports Publishes HIVMA’s Choosing Wisely Resource on CD4 Testing
Interested in Influenza Vaccine Delivery? Earn CMEs by Using a New Physician Resource from NFID and ICID
In Memoriam: D.A. Henderson, MD, MPH
In Memoriam: Lenae Fountain-Moss
In Memoriam: Leland F. Powers
Member Report
Be Part of the Solution at IDWeek Town Hall
IDSA’s Long-Standing Priorities Reflected in UN Declaration for Fighting AMR
Countdown to IDWeek 2016
Journal Club
IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add '' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.